Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 6, 2013, Pages 524-537

  Gupta, Pal ^a   Mullin, Katherine ^a   Nielssen, Olav ^b,c,d   Harris, Anthony ^d   Large, Matthew ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cannabis; First episode psychosis; Psychosis; Schizophrenia; Substance use

Indexed keywords

ADDICTION SEVERITY INDEX; BRIEF PSYCHIATRIC RATING SCALE; CANNABIS SMOKING; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; NEGATIVE SYNDROME; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SOCIAL DISABILITY; SUBSTANCE ABUSE; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW;

CANNABIS; FIRST-EPISODE PSYCHOSIS; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE USE;

ADAPTATION, PSYCHOLOGICAL; DEPRESSION; DRUG USERS; HUMANS; PROGNOSIS; PSYCHOTIC DISORDERS; SYMPTOM ASSESSMENT;

EID: 84880568274     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412474071     Document Type: Review

References (57)

1. Abel KM, Drake R and Goldstein JM (2010) Sex differences in schizophrenia. International Review of Psychiatry 22: 417-428.
2. Addington J and Addington D (1998) Effect of substance misuse in early psychosis. British Journal of Psychiatry Supplement 172: 134-136.
3. Baker AL, Hides L and Lubman DI (2010) Treatment of cannabis use among people with psychotic or depressive disorders: A systematic review. Journal of Clinical Psychiatry 71: 247-254.
4. Barnes TR, Mutsatsa SH, Hutton SB, et al. (2006) Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188: 237-242.
5. Barrowclough C, Emsley R, Eisner E, et al. (2011) Does change in cannabis use in established psychosis affect clinical outcome? Schizophrenia Bulletin. Epub ahead of print 29 Oct 2011.
6. Bartels SJ, Teague GB, Drake RE, et al. (1993) Substance abuse in schizophrenia: Service utilization and costs. Journal of Nervous and Mental Disorder 181: 227-232.
7. Borenstein B, Hedges LV, Higgins JTP, et al. (2009) Introduction to Meta- Analysis. Chichester, UK. Wiley.
8. Carey KB, Carey MP and Simons JS (2003) Correlates of substance use disorder among psychiatric outpatients: Focus on cognition, social role functioning, and psychiatric status. Journal of Nervous and Mental Disorder 191: 300-308.
9. Compton MT, Kelley ME, Ramsay CE, et al. (2009) Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry 166: 1251-1257.
10. Cuffel BJ and Chase P (1994) Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. Journal of Nervous and Mental Disorder 182: 342-348.
11. Dixon L, Haas G, Weiden PJ, et al. (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry 148: 224-230.
12. Elbogen EB and Johnson SC (2009) The intricate link between violence and mental disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 66: 152-161.
13. Faber G, Smid HG, Van Gool AR, et al. (2012) Continued cannabis use and outcome in first-episode psychosis: Data from a randomized, open-label, controlled trial. Journal of Clinical Psychiatry 73: 632-638.
14. Fazel S, Gulati G, Linsell L, et al. (2009) Schizophrenia and violence: Systematic review and meta-analysis. PLoS Medicine 6: e1000120.
15. Fowler IL, Carr VJ, Carter NT, et al. (1998) Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin 24: 443-455.
16. González-Pinto A, Alberich S, Barbeito S, et al. (2011) Cannabis and first-episode psychosis: Different long-term outcomes depending on continued or discontinued use. Schizophrenia Bulletin 37: 631-639.
17. Grech A, Van Os J, Jones PB, et al. (2005) Cannabis use and outcome of recent onset psychosis. European Psychiatry 20: 349-353.
18. Gregg L, Barrowclough C and Haddock G (2007) Reasons for increased substance use in psychosis. Clinical Psychology Review 27: 494-510.
19. Hambrecht M and Hafner H (1996) Substance abuse and the onset of schizophrenia. Biological Psychiatry 40: 1155-1163.
20. Harris AW, Large MM, Redoblado-Hodge A, et al. (2010) Clinical and cognitive associations with aggression in the first-episode of psychosis. Australian and New Zealand Journal of Psychiatry 44: 85-93.
21. Harrison I, Joyce EM, Mutsatsa SH, et al. (2008) Naturalistic follow-up of co-morbid substance use in schizophrenia: The West London firstepisode study. Psychological Medicine 38: 79-88.
22. Henquet C, Murray R, Linszen D, et al. (2005) The environment and schizophrenia: The role of cannabis use. Schizophrenia Bulletin 31: 608-612.
23. Higgins JP, Thompson SG, Deeks JJ, et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
24. Hinton M, Edwards J, Elkins K, et al. (2007) Reductions in cannabis and other illicit substance use between treatment entry and early recovery in patients with first-episode psychosis. Early Intervention in Psychiatry 1: 259-266.
25. Hirvonen J and Hietala J (2011) Dysfunctional brain networks and genetic risk for schizophrenia: Specific neurotransmitter systems. CNS Neuroscience Therapy 17: 89-96.
26. Kamali M, Kelly L, Gervin M, et al. (2000) The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatrica Scandanavica 101: 452-456.
27. Kavanagh DJ, Waghorn G, Jenner L, et al. (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research 66: 115-124.
28. Kivlahan DR, Heiman JR, Wright RC, et al. (1991) Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hospital and Community Psychiatry 42: 609-614.
29. Korver N, Nieman DH, Becker HE, et al. (2010) Symptomatology and neuropsychological functioning in cannabis using subjects at ultrahigh risk for developing psychosis and healthy controls. Australian and New Zealand Journal of Psychiatry 44: 230-236.
30. Kovasznay B (1991) Substance abuse among veterans with a diagnosis of schizophrenia. Hospital and Community Psychiatry 42: 948-949.
31. Large M, Sharma S, Compton MT, et al. (2011) Cannabis use and earlier onset of psychosis: A systematic meta-analysis. Archives of General Psychiatry 2011; 68: 555-561.
32. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine 6: e1000100.
33. McMillan KA, Enns MW, Cox BJ, et al. (2009) Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Canadian Journal of Psychiatry 54: 477-486.
34. Maremmani I, Lazzeri A, Pacini M, et al. (2004) Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status. Journal of Psychoactive Drugs 36: 235-241.
35. Margolese HC, Malchy L, Negrete JC, et al. (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences. Schizophrenia Research 67: 157-166.
36. Martinez-Arevalo MJ, Calcedo-Ordonez A and Varo-Prieto JR (1994) Cannabis consumption as a prognostic factor in schizophrenia. British Journal of Psychiatry 164: 679-681.
37. Mauri MC, Volonteri LS, De Gaspari IF, et al. (2006) Substance abuse in first-episode schizophrenic patients: A retrospective study. Clinical Practice and Epidemiology in Mental Health 2: 4.
38. Moore TH, Zammit S, Lingford-Hughes A, et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 370: 319-328.
39. Morgan VA, Waterreus A, Jablensky A, et al. (2011) People living with psychotic illness 2010. Report on the Second Australian National Survey. Canberra: Commonwealth of Australia.
40. Mullin K, Gupta P, Compton MT, et al. (2012) Does giving up substance use work for patients with psychosis? A systematic meta-analysis. Australian and New Zealand Journal of Psychiatry 2012; 46: 826-839.
41. Negrete JC and Knapp WP (1986) The effects of cannabis use on the clinical condition of schizophrenics. NIDA Research Monograph 67: 321-327.
42. Novick D, Haro JM, Suarez D, et al. (2010) Predictors and clinical consequences of non adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research 176: 109-113.
43. Pencer A and Addington J (2003) Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience 28: 48-54.
44. Perkins DO, Gu H, Weiden PJ, et al. (2008) Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first-episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: A randomized, double-blind, flexible-dose, multicenter study. Journal of Clinical Psychiatry 69: 106-113.
45. Peters BD, de Koning P, Dingemans P, et al. (2009) Subjective effects of cannabis before the first psychotic episode. Australian and New Zealand Journal of Psychiatry 43: 1155-1162.
46. Rabinowitz J, Bromet EJ, Lavelle J, et al. (1998) Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine 28: 1411-1419.
47. Regier DA, Farmer ME, Rae DS, et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511-2518.
48. Riecher-Rössler A and Häfner H (2000) Gender aspects in schizophrenia: Bridging the border between social and biological psychiatry. Acta Psychiatrica Scandinavica. Supplementum. (407): 58-62.
49. Sorbara F, Liraud F, Assens F, et al. (2003) Substance use and the course of early psychosis: A 2-year follow-up of first-admitted subjects. European Psychiatry 18: 133-136.
50. Swendsen J, Ben-Zeev D and Granholm E (2011) Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. American Journal of Psychiatry 168: 202-209.
51. Talamo A, Centorrino F, Tondo L, et al. (2006) Comorbid substance use in schizophrenia: Relation to positive and negative symptoms. Schizophrenia Research 86: 251-255.
52. Turkington A, Mulholland CC, Rushe TM, et al. (2009) Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry 195: 242-248.
53. Van Dijk D, Koeter MW, Hijman R, et al. (2012) Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study. Schizophrenia Research 137: 50-57.
54. Wade D, Harrigan S, Edwards J, et al. (2006) Substance misuse in firstepisode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry 189: 229-234.
55. Wade D, Harrigan S, McGorry PD, et al. (2007) Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. Journal of Clinical Psychiatry 68: 767-774.
56. Wisdom JP, Manuel JI and Drake RE (2011) Substance use disorder among people with first-episode psychosis: A systematic review of course and treatment. Psychiatric Services 62: 1007-1012.
57. Yee NY, Large MM, Kemp RI, et al. (2011) Severe non-lethal violence during psychotic illness. Australian and New Zealand Journal of Psychiatry 45: 466-472.